MedPath

Compare the effect of Arjuna and Ashwagandha in Hypertension

Phase 2
Not yet recruiting
Conditions
Metabolic disorder, unspecified. Ayurveda Condition: VYANAVATAKOPAH,
Registration Number
CTRI/2025/05/087233
Lead Sponsor
Dr Suman Prasad Sahu
Brief Summary

This study is randomised, parallel group, multiple arm prospective trail to study the effect of Arjuna and Ashwagandha in the management of Hypertension in a group of 60 patients. This study will be conducted in Government Ayurvedic College and Hospital,patna,Bihar in the department of Kayachikitsa. Follow up will be done every 15 days for total duration of study i.e of 60 days.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Male
Target Recruitment
60
Inclusion Criteria
  • 1.Patient willing for trial.
  • 2.The sign and symptoms based on both Ayurvedic as well as Modern view.
  • 3.The age group of patients will be between 31-60 years.
  • Stage 1 of Primary Hypertension.
Exclusion Criteria
  • 1.Hypertension with associated complications.
  • 2.Pregnant women.
  • 3.Patient having Diabetes, CKD.
  • 4.Patient having secondary hypertension.
  • 5.Patients suffering from chronic disease like AIDS, Cancer, T.B, Cardiac Complication.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The improvement in the patients will be assessed mainly on the basis of changes in qualitative and quantitative parameters before and after the treatment.60 days
Secondary Outcome Measures
NameTimeMethod
Repeated measurement of systolic and diastolic pressure will be done and the analysis will be done According to 8th JNC criteria for the diagnosis of hypertension.60 days

Trial Locations

Locations (1)

Government Ayurvedic College and Hospital, Kadamkuan, Patna-800003

🇮🇳

Patna, BIHAR, India

Government Ayurvedic College and Hospital, Kadamkuan, Patna-800003
🇮🇳Patna, BIHAR, India
Dr Suman Prasad Sahu
Principal investigator
8825321766
sahusuman133@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.